BAC
Bank of America Corporation
BAC has the edge over OMF overall, supported by stronger fundamentals and stronger valuation.
OMF
OneMain Holdings, Inc.
OMF's outlook is improving, though it still trails on the overall score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
OMF Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
OMF's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like OMF.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over OMF in the historical PE scenario, which offers more potential upside but is not a forecast.
OMF PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4.8x | $31.69 | -42% |
| Forward | 7.1x | $54.38 | — |
| Fair | 7.9x | $51.66 | -5% |
| Current | 8.3x | $54.38 | — |
| Expensive | 10x | $67.63 | +24% |
Historical ranges are pointers, not guarantees.
OMF's PE is in its fair range at 8.3x. If earnings grow as analysts expect, today's price would be 7.1x next year's earnings.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
OMF Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for OMF, with profitability improving. However, they disagree widely on these estimates.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over OMF on earnings, with more consistent year-over-year improvement.
OMF Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.67 | +17% |
| Q3 2026 | $6.56 | +11% |
| Q2 2026 | $6.63 | +20% |
| Q1 2026 | $6.71 | +42% |
| Q4 2025 | $6.56 | +55% |
| Q3 2025 | $5.90 | +29% |
| Q2 2025 | $5.54 | +14% |
| Q1 2025 | $4.73 | -7.8% |
| Q4 2024 | $4.24 | -20% |
OMF's earnings per share have fallen from their peak: $6.56 over the past year, against $10.50 in late 2021.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over OMF on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over OMF on profitability, with a higher operating margin.
OMF Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.4B | +10% |
| Q2 2026 | $1.3B | +8.3% |
| Q1 2026 | $1.3B | +6.6% |
| Q4 2025 | $1.3B | +10% |
| Q3 2025 | $1.2B | +6.2% |
| Q2 2025 | $1.2B | +9.3% |
| Q1 2025 | $1.2B | +10% |
| Q4 2024 | $1.2B | +5.8% |
OMF's revenue has grown year over year for 14 quarters in a row: $1.4B last quarter, up 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | -4.1 points |
| Q2 2026 | 15% | -2.8 points |
| Q1 2026 | 23% | +0.2 points |
| Q4 2025 | 19% | +5.3 points |
| Q3 2025 | 21% | +3.5 points |
| Q2 2025 | 18% | +9.5 points |
| Q1 2025 | 23% | +4.3 points |
| Q4 2024 | 14% | -6 points |
OMF's operating margin was 17% last quarter, down 4.1 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
OMF Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $808M | -2.4% |
| Q2 2026 | $800M | +3.4% |
| Q1 2026 | $739M | +11% |
| Q4 2025 | $865M | +15% |
| Q3 2025 | $828M | +22% |
| Q2 2025 | $774M | +8.7% |
| Q1 2025 | $665M | +19% |
| Q4 2024 | $752M | +11% |
OMF has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over OMF on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
OMF Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -271K shares |
| 1 year | -3.3% | -3.9M shares |
| 3 years | -4.4% | -5.3M shares |
| 5 years | -13% | -17.4M shares |
| Available history | -15% | -20.8M shares |
OMF has 115M diluted shares, down 3.3% from a year ago, with $244M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $34M |
| Q2 2026 | $32M |
| Q1 2026 | $107M |
| Q4 2025 | $71M |
| Q3 2025 | $33M |
| Q2 2025 | $21M |
| Q1 2025 | $16M |
| Q4 2024 | $3M |
OMF spent $244M buying back its own shares over the past year, about three times what it spent the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC has the edge over OMF on leverage, with a lower net debt burden relative to earnings.
OMF Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 18.2x | High |
| Q2 2026 | 17.1x | High |
| Q1 2026 | 16.4x | High |
| Q4 2025 | 16.9x | High |
| Q3 2025 | 18.1x | High |
| Q2 2025 | 18.6x | High |
| Q1 2025 | 20.5x | High |
| Q4 2024 | 22.2x | High |
OMF's net debt is about 18 years of its operating earnings (EBITDA), about the same as a year ago. Net leverage isn't a meaningful measure for financial services companies like OMF.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
OMF Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.1 | Neutral |
| Stochastic | 13.3 | Oversold |
OMF's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
OMF PE vs Financial Services Sector
| Metric | OMF | Sector median | Relative |
|---|---|---|---|
| PE | 8.3x | 13x | 36% below |
| PE % | 54 | 63 | 9 pts below |
OMF has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
OMF Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $56.0 | 2.9% below |
| 20 week MA | $59.7 | 8.9% below |
| 50 week MA | $59.5 | 8.6% below |
| 100 week MA | $57.0 | 4.6% below |
| 200 week MA | $51.0 | 6.5% above |
OMF has fallen below most of its moving averages, though it's still 6.5% above its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over OMF on returns for 2026, with the stronger performance.
OMF Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $42.6 | $46.7 | +9.7% |
| 2021 | $46.7 | $50.2 | +7.4% |
| 2022 | $50.2 | $33.2 | -34% |
| 2023 | $33.2 | $49.2 | +48% |
| 2024 | $49.2 | $52.8 | +7.3% |
| 2025 | $52.8 | $69.1 | +31% |
| 2026 YTD | $69.1 | $54.4 | -21% |
OMF has finished higher in five of the last six years. It's down 21% so far in 2026.